Pfizer Announces $0.43 Quarterly Dividend
Pfizer (NYSE: PFE) has declared a quarterly dividend of $0.43 per share, consistent with its previous payout levels. The forward yield is 6.25%, and the payment will be made on December 7 to shareholders registered as of November 6. Shareholders must own stock before this date to receive the dividend. The announcement reflects stability in Pfizer's dividend policy amid ongoing financial performance improvements, including cost-cutting initiatives and a growing drug pipeline. Analysts have highlighted these factors as supporting reasons for considering Pfizer a buy ahead of broader market recognition or regulatory changes like those under the Medicare Part D Low-Income Subsidy (LOE) program. Pfizer is also participating in a new 340B rebate pilot alongside companies such as AbbVie, Amgen, and GSK. Additionally, recent phase 3 data has reinforced confidence in its drug candidate Litfulo for treating vitiligo.
Topics: dividends pharmaceutical industry